Basic and Clinical Andrology

Table 5 Shows a paired comparison of baseline scores and post duloxetine and post placebo in group B

From: Daily intake of 30 mg duloxetine is effective in decreasing premature ejaculation severity: a prospective randomized placebo-controlled cross over clinical trial

Group B	Baseline		After placebo		p-value	Baseline		After duloxetine		p-value
Group B	Median	IQR	Median	IQR	p-value	Median	IQR	Median	IQR	p-value
AIPE^a	19.5	8–30	19.5	8–30	1.000	19.5	8–30	26	14–34	< 0.001^d
IELT(Sec)^b	60	30–120	60	30–120	1.000	60	30–120	240	120–240	< 0.001^d
Male SQOL^c	20	16–34	21	16–33	1.000	21	16–33	40	30–55	< 0.001^d

^aAIPE the Arabic index of premature ejaculation
^bIELT Intravaginal ejaculatory latency time
^cMale SQOL (sexual quality of life questionnaire- male version) before and after treatment group B
^dP value was calculated using Wilcoxon sign rank test

Back to article page

ISSN: 2051-4190

Contact us

Submission enquiries: kristine.lamar@springernature.com
General enquiries: info@biomedcentral.com